BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Dec 9, 2026; 15(4): 121263
Published online Dec 9, 2026. doi: 10.5409/wjcp.121263
Table 2 Biochemical parameters of patients with UGT1A1-related disorders, n (%)/median (interquartile range)
Biochemical parameters
Normal range
Total, n = 35 (100)
CNS-I, n = 1 (2.9)
CNS-II, n = 7 (20.0)
GS, n = 27 (77.1)
P value1 (95%CI)
Hemoglobin (g/dL)12.0-14.510.9 ± 2.110.911.0 ± 1.710.9 ± 2.20.955 (-1.8, 1.9)2
Hematocrit (%)33-4533.2 ± 5.832.133.9 ± 3.833.1 ± 6.40.721 (-4.3, 6.1)2
RBC (× 1012/L)3.9-5.24.4 ± 0.95.34.5 ± 0.94.4 ± 0.90.732 (-0.7, 0.9)2
Reticulocyte (%) (n = 32)0.5-1.52.7 (1.9-5.6) 1.91.8 (1.1-6.1) (n = 6)3.0 (2.1-5.3) (n = 25)0.3683
Platelet count (× 109/L) 150-400 286 (221-396)263331 (259-403)282 (221-381)0.3383
Total protein (g/L)57-8274 ± 5.962.070.3 ± 3.974.8 ± 5.90.086 (-9.1, 0.62)2
Serum albumin (g/L)38-5444.5 ± 3.437.044.1 ± 5.344.7 ± 2.90.706 (-3.6, 2.4)2
Total bilirubin at presentation (μmol/L)5-2189.7 ± 52.7409105.3 ± 46.288.2 ± 53.80.447 (-28.2, 62.5)2
Direct bilirubin (μmol/L)≤ 5.014 (10-18)4.015 (8-16)14 (11-19)0.4683
Indirect bilirubin at presentation (μmol/L)≤ 1872 (24-126)40595 (40-122)68 (23-126)0.1943
Maximum total bilirubin (μmol/L)5-21147 (98-228)409188 (121-227) 133 (91-238)0.4063
Maximum indirect bilirubin (μmol/L)≤ 18122.7 (82-210)405173 (109-210)119 (67-182)0.2973
ALP (U/L)142-335185 (132-254)246254 (132-343) 180 (118-204)0.3833
ALT (U/L)≤ 3317 (12-25)10617 (11-25)17 (12-22)0.9833
GGT (U/L)≤ 3811 (8-20)2015 (7-38)10 (9-16)0.9323
Vitamin D level (nmol/L) (n = 27)> 5031.3 ± 11.54831.7 ± 6.0 (n = 3)30.5 ± 11.8 (n = 23)0.871 (-13.3, 15.6)2


Write to the Help Desk